Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-02-18 @ 9:47 AM
Study NCT ID:
NCT00875667
Status:
COMPLETED
Last Update Posted:
2019-09-16
First Post:
2009-04-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-01
First Submit QC Date:
None
Study First Post Date:
2009-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-28
Results First Submit QC Date:
None
Results First Post Date:
2019-09-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-13
Last Update Post Date:
2019-09-16
Last Update Post Date Type:
ACTUAL